MyFinsight
Home
Blog
About
Contact
Download
Download image
Net (loss) income
-$23,058,135
Loss (gain) from
change in fair value of...
$2,791,813
Loss from change in
fair value of...
$6,743,736
Loss on equity method
investment
-$38,634
Loss from operations
-$13,483,952
Selling, general and
administrative
$8,612,141
Research and development
$3,634,352
Gross profit
-$1,237,459
Revenues, net
-$1,207,833
Cost of revenues
$29,626
Revenues, net
-$1,207,833
Revenues, net
-$1,207,833
Back
Back
Income Statement
source: myfinsight.com
Outlook Therapeutics, Inc. (OTLK)
Outlook Therapeutics, Inc. (OTLK)